Kowalski, Katya (2021) The new leaf: beyond Brexit, countering Covid. London: Volteface.
Preview | Title | Contact |
---|---|---|
|
PDF (The new leaf: beyond Brexit, countering Covid.)
- Published Version
481kB |
This report has honed in on the opportunities that medical cannabis and CBD bring through an economic, innovation and regulatory lens.
Chapter one focuses on the economic opportunity, using existing evidence to paint a clear picture as to why the UK is an attractive jurisdiction for business.
Chapter two examines the opportunities for innovation through a case study analysis of two cannabis companies: Kanabo and CiiTECH.
Chapter three discusses the UK’s CBD advantage.
Chapter four highlights the next steps for the industry.
B Substances > Cannabis product (Cannabinoids) > Cannabinol / Cannabidiol (CBD oil)
E Concepts in biomedical areas > Medical substance > Medical / medicinal cannabis
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Viral disease / infection > Coronavirus (COVID-19)
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Drug decriminalisation or legalisation policy
MP-MR Policy, planning, economics, work and social services > Economic policy
VA Geographic area > Europe > United Kingdom
Repository Staff Only: item control page